Europe's Haematococcus Pluvialis Market Envisions $35 Million by 2030
Explore $35 million Europe Haematococcus Pluvialis Market: Get exclusive insights on key market trends, segments, geographical analysis, & competitive analysis!n
- Europe Haematococcus Pluvialis Market
- Haematococcus Pluvialis Market
- Haematococcus
- Haematococcus pluvialis microalgae
- Haematococcus pluvialis astaxanthin
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Europe Haematococcus Pluvialis Market to Reach $35 Million by 2030
Europe Haematococcus Pluvialis Market-2023-2030 Meticulous Research a leading global market research company, published a research report titled Europe Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}), Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography - Forecast to 2030 . According to this latest publication from Meticulous Research , in terms of value, the Europe haematococcus pluvialis market is projected to reach $35 million by 2030, at a CAGR of 13.4% from 2023 to 2030. In terms of volume, this market is projected to reach 241.44 tons by 2030, at a CAGR of 14.5% from 2023 to 2030. The growth of this market is driven by increasing demand for natural astaxanthin for nutraceutical applications, the growing demand for natural food colorants, and increasing awareness of clean-label products. However, the high production cost is expected to restrain the growth of this market. The rising demand for natural astaxanthin and the growing use of natural astaxanthin in poultry and aquaculture is expected to create market growth opportunities. However, the complex production process for haematococcus pluvialis is a major challenge for the players operating in this market. Additionally, the increasing need for natural self-grooming products is a prominent trend in the Europe haematococcus pluvialis market. The Europe haematococcus pluvialis market is segmented by product (astaxanthin ingredients {astaxanthin oleoresin, beadlets, whole biomass powder, water dispersible powder}), astaxanthin bulk finished products {capsules/softgel, tablets}); application (nutraceuticals, aquaculture & animal feed, cosmetics, food & beverages, pharmaceuticals); and country (Germany, the U.K., Italy, France, Sweden, Spain, Russia, Netherlands, Denmark, Poland, and the Rest of Europe). Based on product, in 2023, the astaxanthin ingredients segment is expected to account for the largest share of the Europe haematococcus pluvialis market. The large share of this segment is mainly attributed to the growing end-use applications of astaxanthin ingredients, rising awareness about preventive healthcare & nutraceuticals, rising demand for natural antioxidants, growing cosmetic & personal care markets, and government initiatives to support the aquaculture industry. Based on application, in 2023, the nutraceuticals segment is expected to account for the largest share of the Europe haematococcus pluvialis market. The large market share of this segment is mainly attributed to the increasing demand for natural astaxanthin derived from haematococcus in the nutraceuticals industry due to its potential effects on various diseases, including cancers, hypertension, diabetes, cardiovascular, gastrointestinal, and liver neurodegenerative, and several skin diseases. Geographic Review Page 1 of 3 Meticulous Research| sales@meticulousresearch.com
Europe Haematococcus Pluvialis Market-2023-2030 This research report analyzes major countries and provides a comprehensive analysis of the market in Europe (Germany, the U.K., Italy, France, Sweden, Spain, Russia, the Netherlands, Denmark, Poland, and the Rest of Europe). In 2023, Germany is expected to account for the largest share of the Europe haematococcus pluvialis market, followed by the U.K. and Italy. Germany s major market share is attributed to the widespread use of haematococcus pluvialis ingredients in the country, the increasing number of health-conscious consumers, the rising awareness of environmental issues, and the willingness of consumers to pay higher prices for natural and environment-friendly products. In addition, consumers appeal toward health and wellness products like nutraceuticals with rising awareness generated through government advertisements featuring healthy lifestyles, and growing body consciousness is further expected to support the growth of the haematococcus pluvialis market in the country. This rise in health awareness has stimulated consumer interest in healthy foods and related products, compelling food processors to consider marketing food and drinks on health platforms as a means of differentiation. This trend has resulted in the widespread use of natural antioxidants in food products, subsequently driving the demand for haematococcus pluvialis-derived products from end-use industries. education programs, media Key Players The haematococcus pluvialis market is characterized by a moderately competitive scenario due to the presence of many large- and small-sized global, regional, and local players in Europe. The key players operating in the Europe haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Kl tze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), BEIJING GINGKO GROUP (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algal f Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investiga o, Lda (Portugal), and Astaxa GmbH (Germany). Download Sample Copy Here: https://www.meticulousresearch.com/download- sample-report/cp_id=5496 Key Questions Answered in the Report- What is the current value of revenue generated by the Europe haematococcus pluvialis market? Page 2 of 3 Meticulous Research| sales@meticulousresearch.com
Europe Haematococcus Pluvialis Market-2023-2030 At what rate is the Europe haematococcus pluvialis market projected to grow for the next 5-7 years? What is the historical market size and growth rate for the Europe haematococcus pluvialis market? What are the major factors impacting the growth of this market? What are the major opportunities for existing players and new entrants in the market? Which product and application segments create major traction for the manufacturers in this market? What are the key country-level trends in this market? Which countries are likely to offer significant growth opportunities for the manufacturers in this market during the analysis period? Who are the major players in the Europe haematococcus pluvialis market? What are their specific product offerings in this market? What recent developments have taken place in the Europe haematococcus pluvialis market? What impact have these strategic developments created on the market? Contact Meticulous Email- sales@meticulousresearch.com Contact Connect with us on research Us: Research Sales- +1-646-781-8004 LinkedIn- https://www.linkedin.com/company/meticulous- Page 3 of 3 Meticulous Research| sales@meticulousresearch.com